M-Vizion™ Macroscopic Radiographic Study
Start Date
10/12/2022
Completion Date
6/1/2026
Summary
Study of the patient's subsidence after revision hip arthroplasty by assessing gross stem subsidence in the femoral canal.
Detailed Description
The aim of this study is to evaluate the M-Vizion modular stem performance in patients who undergo total hip replacement according to the standard practice. It is expected that subjects receiving revision hip arthroplasty with the Medacta M-Vizion™ modular hip stem will have less than 5mm of stem subsidence at 2 years.
Eligibility Criteria
Age Range: 21 years to 80 years
Interventions
revision hip arthroplasty
Conditions
Locations
Northwestern Medicine
Chicago, Illinois 60611
United States
New England Baptist Hospital
Boston, Massachusetts 02120
United States
Beth Israel Deaconess Medical Center
Boston, Massachusetts 02215
United States
Dartmouth Health
Lebanon, New Hampshire 03756
United States
OrthoCarolina Research Institute, Inc.
Charlotte, North Carolina 28207
United States
Geisinger Medical Center
Danville, Pennsylvania 17822
United States
University of Utah Department of Orthopaedics
Salt Lake City, Utah 84108
United States